Lnc524369 promotes hepatocellular carcinoma progression and predicts poor survival by activating YWHAZ-RAF1 signaling

Figure 4 The expression of Lnc524369/YWHAZ/RAF1 protein in hepatocellular carcinoma patients and its survival analysis. A: High differentiation of human hepatocellular carcinoma (HCC) pathology; B: Moderate differentiation of human HCC pathology; C: Low differentiation of human HCC pathology; D: Lnc524369 relative level was positively corelated with pathological grade of HCC (RS: 0.604, P < 0.01); E: YWHAZ protein level was higher in HCC tissue than para-HCC tissue (P < 0.01); F: RAF1 protein level was higher in HCC tissue than para-HCC tissue (P < 0.001); G: The western blot band of YWHAZ protein; H: Survival analysis for YWHAZ mRNA of HCC patients at TCGA database; I: The RAF1 protein of the western blot in HCC tissue and para-HCC tissue; J: Survival analysis for RAF1 mRNA of HCC patients at TCGA database. HCC: Hepatocellular carcinoma.